(MedPage Today) — At the FDA’s request, delandistrogene moxeparvovec (Elevidys), the only approved gene therapy for Duchenne muscular dystrophy, will carry a black box warning for acute liver injury and acute liver failure, drugmaker Sarepta Therapeutics…
Source link : https://www.medpagetoday.com/neurology/generalneurology/116559
Author :
Publish date : 2025-07-17 20:04:00
Copyright for syndicated content belongs to the linked Source.
